NO145162C - Analogifremgangsmaate ved fremstilling av nye cholecaliciferolderivater, hvilke kontrollerer kalsium-metabolismen hos varmblodige dyr - Google Patents

Analogifremgangsmaate ved fremstilling av nye cholecaliciferolderivater, hvilke kontrollerer kalsium-metabolismen hos varmblodige dyr

Info

Publication number
NO145162C
NO145162C NO752150A NO752150A NO145162C NO 145162 C NO145162 C NO 145162C NO 752150 A NO752150 A NO 752150A NO 752150 A NO752150 A NO 752150A NO 145162 C NO145162 C NO 145162C
Authority
NO
Norway
Prior art keywords
cholecaliciferold
bloody
animals
derivatives
hot
Prior art date
Application number
NO752150A
Other languages
English (en)
Norwegian (no)
Other versions
NO145162B (no
NO752150L (de
Inventor
Toru Takeshita
Yoshinobu Hashimoto
Hiroyuki Kawashima
Sachio Ishimoto
Nobuo Ikekawa
Masuo Morisaki
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP6866474A external-priority patent/JPS539222B2/ja
Priority claimed from JP14133074A external-priority patent/JPS5168557A/ja
Priority claimed from JP14132974A external-priority patent/JPS5168556A/ja
Priority claimed from JP49141332A external-priority patent/JPS5168560A/ja
Priority claimed from JP14133174A external-priority patent/JPS5320989B2/ja
Priority claimed from JP14902174A external-priority patent/JPS5176255A/ja
Priority claimed from JP14901874A external-priority patent/JPS5176253A/ja
Priority claimed from JP14902074A external-priority patent/JPS5176254A/ja
Priority claimed from JP14901774A external-priority patent/JPS5176252A/ja
Priority claimed from JP14902274A external-priority patent/JPS5176259A/ja
Application filed by Teijin Ltd filed Critical Teijin Ltd
Publication of NO752150L publication Critical patent/NO752150L/no
Publication of NO145162B publication Critical patent/NO145162B/no
Publication of NO145162C publication Critical patent/NO145162C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
NO752150A 1974-06-18 1975-06-17 Analogifremgangsmaate ved fremstilling av nye cholecaliciferolderivater, hvilke kontrollerer kalsium-metabolismen hos varmblodige dyr NO145162C (no)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
JP6866474A JPS539222B2 (de) 1974-06-18 1974-06-18
JP14133074A JPS5168557A (en) 1974-12-09 1974-12-09 1 arufua 244 jihidorokishikorekarushifuerooruno seizoho
JP14133174A JPS5320989B2 (de) 1974-12-09 1974-12-09
JP49141332A JPS5168560A (en) 1974-12-09 1974-12-09 1 arufua 244 jihidorokishikorekarushifuerooruno bunriho
JP14132974A JPS5168556A (en) 1974-12-09 1974-12-09 1 arufua 244 jihidorokishikorekarushifuerooruno seizohoho
JP14902174A JPS5176255A (en) 1974-12-27 1974-12-27 1 arufua * 24 * s * jihidorokishikorekarushifueroorunoseizohoho
JP14901874A JPS5176253A (en) 1974-12-27 1974-12-27 1 arufua *24 * r * jihidorokishikorekarushifueroorunoseizohoho
JP14902074A JPS5176254A (en) 1974-12-27 1974-12-27 1 arufua * 24 * s * jihidorokishikorekarushifueroorunoseizoho
JP14901774A JPS5176252A (en) 1974-12-27 1974-12-27 1 arufua *24 * r * jihidorokishikorekarushifueroorunoseizoho
JP14902274A JPS5176259A (en) 1974-12-27 1974-12-27 244 benzoiruokishikoresuteroorujudotaino 24 iepimaanobunriho

Publications (3)

Publication Number Publication Date
NO752150L NO752150L (de) 1975-12-19
NO145162B NO145162B (no) 1981-10-19
NO145162C true NO145162C (no) 1982-01-27

Family

ID=27580092

Family Applications (1)

Application Number Title Priority Date Filing Date
NO752150A NO145162C (no) 1974-06-18 1975-06-17 Analogifremgangsmaate ved fremstilling av nye cholecaliciferolderivater, hvilke kontrollerer kalsium-metabolismen hos varmblodige dyr

Country Status (10)

Country Link
US (1) US4022891A (de)
CA (1) CA1051442A (de)
CH (1) CH618669A5 (de)
DE (1) DE2526981C3 (de)
DK (1) DK142410B (de)
FR (1) FR2275196A1 (de)
GB (2) GB1508043A (de)
NL (1) NL7507268A (de)
NO (1) NO145162C (de)
SE (1) SE413096B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1088094B (it) * 1976-10-14 1985-06-04 Hoffmann La Roche Derivati del pregnano
JPS53147051A (en) * 1977-05-24 1978-12-21 Teijin Ltd 1alpha-hydroxy-24-dehydro-vitamin d3 and its preparation
JPS5822479B2 (ja) * 1977-09-07 1983-05-09 帝人株式会社 １α−ヒドロキシ−２４−オキソ−ビタミンＤ↓３およびその製造法
US4225596A (en) * 1978-10-13 1980-09-30 Wisconsin Alumni Research Foundation Method for treating calcium imbalance and improving calcium absorption in mammals
LU80545A1 (de) * 1978-11-17 1980-06-05 Hoffmann La Roche Verfahren zur herstellung von 1a,3s-dihydroxy->5-steroiden
US4230701A (en) * 1979-03-21 1980-10-28 Hoffmann-La Roche Inc. Administration of biologically active vitamin D3 and vitamin D2 materials
US4335120A (en) * 1979-03-21 1982-06-15 Hoffmann-La Roche Inc. Administration of biologically active vitamin D3 and vitamin D2 materials
JPS55136229A (en) * 1979-04-10 1980-10-23 Teijin Ltd Adjustment of bone metabolism in warm-blooded animal and drug for it
JPS5626820A (en) * 1979-08-10 1981-03-16 Chugai Pharmaceut Co Ltd Immunosuppressing agent
US4338250A (en) * 1981-04-27 1982-07-06 Wisconsin Alumni Research Foundation 1-Hydroxylation process
CA1272953A (en) 1984-10-08 1990-08-21 Yuji Makino Pharmaceutical composition for external use containing active-type vitamin d.sub.3
JPH0749435B2 (ja) * 1988-07-04 1995-05-31 帝人株式会社 １α，３β，２４−トリヒドロキシ−△▲上５▼−ステロイド類の製造方法
US5532228A (en) * 1990-02-06 1996-07-02 Schering Aktiengesellschaft Side-chain homologous vitamin D derivatives, process for their production, pharmaceutical preparations containing these derivatives and their use as pharmaceutical agents
WO1992012165A1 (en) * 1991-01-08 1992-07-23 Lunar Corporation METHODS FOR PREPARATION AND USE OF 1α,24-DIHYDROXY VITAMIN D¿2?
US6166000A (en) * 1991-01-08 2000-12-26 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-Dihydroxy vitamin . D.sub2
US5786348A (en) * 1991-01-08 1998-07-28 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxy vitamin D2
US6251883B1 (en) 1991-01-08 2001-06-26 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxy vitamin D2
US6538037B2 (en) 1991-01-08 2003-03-25 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
US20040009958A1 (en) * 1991-01-08 2004-01-15 Bone Care International, Inc. Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2
EP0614456B1 (de) * 1992-08-28 1999-06-09 Bone Care International, Inc. 1alpha,24(s)-dihydroxy vitamin d2, seine synthese und verwendung
IL107185A (en) * 1992-10-06 1998-02-22 Schering Ag History of 52-carboxylic acid, processes for their preparation and pharmaceutical preparations containing them
US5869472A (en) * 1994-07-18 1999-02-09 Bone Care International, Inc. Synthesis of 1α-hydroxy vitamin D
US6362350B1 (en) 1999-07-01 2002-03-26 Wisconsin Alumni Research Foundation Crystalline 1α, 24(S)-dihydroxyvitamin D2 and method of purification thereof
US7129230B2 (en) 2001-03-12 2006-10-31 Nestec S.A. Method and product for treating cancer in pets
US7094775B2 (en) * 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
US20060003950A1 (en) * 2004-06-30 2006-01-05 Bone Care International, Inc. Method of treating prostatic diseases using a combination of vitamin D analogues and other agents
TW200714580A (en) * 2005-10-14 2007-04-16 Formosa Lab Inc Process for preparing vitamin D analogs
US20090233889A1 (en) * 2008-03-12 2009-09-17 Uttam Saha Stabilized 1,25-dihydroxyvitamin d2 and method of making same
KR102300311B1 (ko) 2017-04-18 2021-09-10 연성정밀화학(주) 타칼시톨의 제조방법 및 그를 위한 중간체

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3901928A (en) * 1973-01-10 1975-08-26 Robert Henry Hesse 1' ,3' -dihydroxy steroid-5-enes method of preparing same and their use for preparing 1' -hydroxy-25-hydrogen vitamin d compounds
US3928397A (en) * 1973-03-02 1975-12-23 Eisai Co Ltd New 5-cholestene derivatives and preparation thereof

Also Published As

Publication number Publication date
GB1508042A (en) 1978-04-19
FR2275196A1 (fr) 1976-01-16
SE413096B (sv) 1980-04-14
DE2526981C3 (de) 1979-03-01
DE2526981B2 (de) 1978-06-29
DE2526981A1 (de) 1976-01-15
CH618669A5 (de) 1980-08-15
NO145162B (no) 1981-10-19
NL7507268A (nl) 1975-12-22
DK273375A (de) 1975-12-19
NO752150L (de) 1975-12-19
DK142410C (de) 1981-03-23
FR2275196B1 (de) 1978-10-06
GB1508043A (en) 1978-04-19
US4022891A (en) 1977-05-10
SE7506560L (sv) 1975-12-19
DK142410B (da) 1980-10-27
CA1051442A (en) 1979-03-27

Similar Documents

Publication Publication Date Title
NO145162C (no) Analogifremgangsmaate ved fremstilling av nye cholecaliciferolderivater, hvilke kontrollerer kalsium-metabolismen hos varmblodige dyr
NO160211C (no) Analogifremgangsmaate til fremstilling av nye terapeutisk virksomme cefemderivater.
NO144850C (no) Analogifremgangsmaate til fremstilling av immunpotenserende glukosaminderivater.
NO154919C (no) Analogifremgangsmaate ved fremstilling av nye kinazolinderivater.
NO146143C (no) Fremgangsmaate til fremstilling av cellulosemasse
SE409707B (sv) Forfarande for framstellning av sulfoxider, vilka er antagonister mot vissa verkningar av histamin
NO142813C (no) Analogifremgangsmaate ved fremstilling av det anthelminitisk virksomme, nye metyl-5-propyltio-2-benzimidazolkarbamat
SE424324B (sv) Analogiforfarande for framstellning av 1,2-benzisoxazolderivat
NO148921C (no) Analogifremgangsmaate til fremstilling av immunpotenserende peptidderivater.
DK134177C (da) Fremgangsmade til fremstilling af 3-(piperazinoalkyl)-pyrazoler
NO142303C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme oksazolderivater
NO143943C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktiv 3-(4-p-fluorfenyl-1-metylbutyl)-1-hydroksy-6,6,9-trimetyl-7,8,9,10-tetrahydro-6h-dibenzo(b,d)pyran
NO150882C (no) Analogifremgangsmaate ved fremstilling av nye 1,4-benzoksazin-derivater
SE415834B (sv) Analogiforfarande for framstellning av pyrazolderivat
SE407880B (sv) Forfarande for reglering av vridmomentet hos en asynkronmaskin
NO143026C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk virksomme halogenderivater
NO142346C (no) Analogifremgangsmaate til fremstilling av nye terapeutisk aktive kondenserte n-fenylsubstituerte pyrroler
SE428296B (sv) Analogiforfarande for framstellning av substituerade difonylsulfider
DK147004C (da) Analogifremgangsmaade til fremstilling af oxygenerede alkylxanthinderivater
SE419983B (sv) Forfarande for framstellning av finkornig, fast cyanurklorid
DK152120C (da) Analogifremgangsmaade til fremstilling af 4-(2-acyloxy-3-tert.butylaminopropoxy)-indolderivater
NO144039C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk virksomme benzofuranderivater
DK146539C (da) Analogifremgangsmaade til fremstilling af 7alfa-methoxycephalosporin-derivater
SE420089B (sv) Analogiforfarande for framstellning av fenoxipropylaminderivat (acetofenoner)
SE424638B (sv) Analogiforfarande for framstellning av 5,7-dihydroxi-tetrahydroisokinolin derivat